GRK2 enforces androgen receptor dependence in the prostate and prostate tumors-Reference-Cited by-同舟云学术

GRK2 enforces androgen receptor dependence in the prostate and prostate tumors

Published:2020-01-20 Issue:11 Volume:39 Page:2424-2436
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Adler Adam J.,Mittal Payal,Hagymasi Adam T.,Menoret Antoine,Shen Chen,Agliano Federica,Wright Kyle T.,Grady James J.,Kuo Chia-Ling,Ballesteros Enrique,Claffey Kevin P.,Vella Anthony T.

Funder

U.S. Department of Health & Human Services | National Institutes of Health

The Carole and Ray Neag Comprehensive Cancer Center

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/s41388-020-1159-x.pdf

Reference77 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.

2. Denmeade SR, Isaacs JT. A history of prostate cancer treatment. Nat Rev Cancer. 2002;2:389–96.

3. Watson PA, Arora VK, Sawyers CL. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer. 2015;15:701–11.

4. Dehm SM, Schmidt LJ, Heemers HV, Vessella RL, Tindall DJ. Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance. Cancer Res. 2008;68:5469–77.

5. Palmgren JS, Karavadia SS, Wakefield MR. Unusual and underappreciated: small cell carcinoma of the prostate. Semin Oncol. 2007;34:22–9.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational analysis of G-protein-coupled receptor kinase family members as potential targets for colorectal cancer therapy;Egyptian Journal of Medical Human Genetics;2022-09-11

2. Direct Synthesis, Characterization and Theoretical Studies of N‐(6‐Amino‐1,3‐dimethyl‐2,4‐dioxo‐1,2,3,4‐tetrahydropyrimidin‐5‐yl)benzamide Derivatives;ChemistrySelect;2021-01-25

3. A novel GPCR target in correlation with androgen deprivation therapy for prostate cancer drug discovery;Basic & Clinical Pharmacology & Toxicology;2020-12